Treatment with inhibitors at various nodes of the signaling pathway, including PI3K, AKT and mTOR, resulted in impaired growth and migration of medulloblastoma cells using in vitro and in vivo models [83, 84]. Here, PIK3CG is linked to medulloblastoma.